BRIEF-Ruanyun Edai Technology Inc Files For U.S. IPO-March 2024-www.financetom.com

BRIEF-Ruanyun Edai Technology Inc Files For U.S. IPO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Ruanyun Edai Technology Inc Files For U.S. IPO

Aug 30, 2024 10:29 AM

Aug 30 (Reuters) - Ruanyun Edai Technology Inc:

* RUANYUN EDAI TECHNOLOGY INC FILES FOR U.S. IPO - SEC

FILING

* RUANYUN EDAI TECHNOLOGY INC SAYS APPLIED TO LIST ORDINARY

ON NASDAQ UNDER SYMBOL "RYET"

* RUANYUN EDAI TECHNOLOGY INC SEES U.S. IPO OF UP TO 3.75

MILLION

ORDINARY SHARES PRICED TO BE BETWEEN $4.00 AND $5.00 PER SHARE

* RUANYUN EDAI TECHNOLOGY INC SAYS AC SUNSHINE SECURITIES

LLC IS

THE UNDERWRITER TO IPO

Previous page： Why United Airlines (UAL) Stock Hit A New 52-Week High Today Next page： Merck's Keytruda Approved in Japan for Treatment of Lung, Urothelial Cancers

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Why United Airlines (UAL) Stock Hit A New 52-Week High Today

Sep 26, 2024

United Airlines Holdings Inc ( UAL ) shares surged 9.13% to $59.05 on Thursday afternoon, reaching a fresh 52-week high. The rally in airline stocks was fueled by Southwest Airlines Co ( LUV ) unveiling a $2.5 billion stock buyback program, lifting investor sentiment across the sector. What Else: Southwest ( LUV ) also expects its revenue per seat mile...

Merck's Keytruda Approved in Japan for Treatment of Lung, Urothelial Cancers

Sep 26, 2024

07:25 AM EDT, 09/25/2024 (MT Newswires) -- Merck ( MRK ) said Wednesday that Japan's Ministry of Health, Labor and Welfare has approved new indications for Keytruda (pembrolizumab) in certain lung and urothelial cancers. Keytruda in combination with Padcev was approved as a first-line treatment of patients with radically inoperable urothelial carcinoma, Merck ( MRK ) said. The cancer drug...

Market Chatter: Trip.com Investor Prosus Exits in $743 Million Block Trade

Sep 26, 2024

07:13 AM EDT, 09/25/2024 (MT Newswires) -- Trip.com ( TCOM ) investor Prosus fully sold its stake in the Chinese online travel agency in a $743 million block trade, Bloomberg reported Wednesday, citing unnamed sources familiar with the matter. Prosus sold 14.5 million shares of Trip.com ( TCOM ) at $51.40 apiece on Tuesday in the US, marking its final...

Why Is Worthington Enterprises Stock Diving Premarket On Wednesday?

Sep 26, 2024

Worthington Enterprises, Inc ( WOR ). shares are trading lower at a premarket on Wednesday after the company reported worse-than-expected first-quarter financial results. On Tuesday, the company reported a net sales decline of 17.5% Y/Y to $257.3 million, missing the consensus of $300.26 million. The decline was attributed to the deconsolidation of the former Sustainable Energy Solutions (SES) segment in the fourth...